Study S001193

Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record

Registration

Registration: NCT00701935
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: TERMINATED
Enrollment: 80
Start: 2008-08
Primary completion: 2012-01
Lead sponsor: AstraZeneca
Conditions: Diabetes Mellitus
Interventions: DRUG:placebo; DRUG:exenatide
Results posted: TRUE

Registered primary outcomes

Percentage Change in Abdominal Visceral Fat From Baseline to 6 Months [baseline, 6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.